Introduction President Donald Trump signed an executive order on April 18, 2026, directing the Food and Drug Administration to accelerate its review of certain psychedelic compounds, including ibogaine, for the treatment of serious mental illness. The order marks the first time the federal government has formally moved to expedite ibogaine FDA approval, a development that...
Who’s Funding It, Who’s Pushing It, and What’s Standing in the Way The lab-grown food movement has a new frontier target: your morning cup of coffee. What was once confined to speculative tech conferences and fringe food blogs is now attracting hundreds of millions in venture capital, strategic investment from global food giants, and enthusiastic...
When One Giant Swallows Another: Sysco’s Restaurant Depot Deal Could Kill the Variety on Your Plate The $29 billion acquisition making headlines on Wall Street may quietly reshape what ends up on your dinner table — and not in a good way. It happened fast. Just this week, Sysco — already the country’s largest provider...
The Body Keeps the Score As the Global Food Supply Transforms, What Happens to Human Nutrition, Metabolism, and Long-Term Health? The food supply is changing faster than our understanding of what that change means for the human body. We covered the mechanics last time — how industrial seed oils have saturated processed foods, how lab-grown...